vaccine

Documents about vaccine

• 22 U.S.C. § 7624 — Facilitating vaccine development#578030US Code (LII)
• 42 U.S.C. § 300aa-5 — National Vaccine Advisory Committee#594696US Code (LII)
• 42 U.S.C. § 283d — Children’s Vaccine Initiative#595198US Code (LII)
• 42 U.S.C. § 247d-1 — Vaccine tracking and distribution#595392US Code (LII)
• 42 U.S.C. § 239b — Smallpox vaccine injury table#595459US Code (LII)
• Influenza Vaccine Postpartum Questionnaire#350021ClinicalTrials.gov
• Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor#353330ClinicalTrials.gov
• Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma#353343ClinicalTrials.gov
• Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants#4493Europe PMC
• The 15-year bibliometric landscape of glioblastoma vaccines: Emergence of combinatorial immunotherapy#4494Europe PMC
• Serious adverse events following human papillomavirus vaccination: A systematic review and meta-analysis of post-marketing evidence#4601Europe PMC
• Vaccines against chronic <i>Trypanosoma cruzi</i> infection: progress, challenges and future directions#4632Europe PMC
• Vaccine safety for individuals receiving immune checkpoint inhibitor therapy: A narrative review of current literature and recommendations for future research#4645Europe PMC
• Data from: Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle#215127Figshare
• Kinetics of rabies-neutralising antibodies in non-human primates after the injection of adjuvanted and inactivated rabies vaccine#280576HAL (France)

Related topics